Form D · Other Technology
METAVIR THERAPEUTICS, INC
Gardena, CA · CIK 0001830845
Offering snapshot reported Nov 17, 2020 · SEC filing
- Reported sold
- $7.5M Indefinite offering
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Nov 12, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 17, 2020 | Initial | $7,500,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-380727
Source: Form D, filed Nov 17, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ernesto Barron | Executive |
| Glenn Byfield | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
1225 W 190 Th St # 220 A
Gardena, CA, 90248
Gardena, CA, 90248